QuellTX
Maja Piatek has worked in various industries starting from L'ORO DI NAPOLI as a Service Staff where they improved the training and streamlined processes. Maja worked as a Laboratory Assistant at The University of Manchester, Brain Inflammation Laboratory, where they collected and analyzed data for research on the effect of targeting inflammatory proteins in neurodegenerative diseases. As a Merchandise Associate at TK MAXX, Maja oversaw two departments and analyzed previous sales data to optimize merchandising and advertising tactics to increase sales. At Charles River Laboratories, they worked as an Experienced Biologics Manufacturing Operator responsible for producing plasmid DNA for commercial and clinical supply, leading deviations investigations, and implementing CAPAs and SOP updates. Currently, Maja has joined Quell Therapeutics as a Production Scientist I.
Maja Piatek earned a Bachelor of Science degree in Neuroscience from The University of Manchester from 2016 to 2019. Prior to that, they completed their A levels and GCSEs at Cardinal Wiseman RC School from 2009 to 2016, achieving A grades in Biology, B grades in Chemistry and Math, and 10 GCSEs with A*-B grades, including Math and English.
This person is not in the org chart
QuellTX
4 followers
Quell's vision is to become a leading engineered Treg cell therapy company. The company will seek to develop next generation engineered T-regulatory cell (Treg) therapies for a range of solid organ transplant and autoimmune conditions.Quell has been founded by Syncona in partnership with six leading experts in the Treg field, cellengineering, solid organ transplantation and autoimmune diseases: Giovanna Lombardi, Professor of Human Transplant Immunology at Kings College London (KCL), Alberto Sanchez-Fueyo, Professor of Hepatology in the Institute of Liver Studies at KCL, Hans Stauss, Professor of Tumour Immunology and Director of the Institute of Immunity and Transplantation at University College London (UCL), Emma Morris, Professor of Clinical Cell & Gene Therapy and Inflammation, Immunity and Immunotherapeutics Theme Director, National Institute for Health Research University College London Hospitals Biomedical Research Centre, Marc Martinez-Llordella, Senior Lecturer in the Institute of Liver Studies at KCL and Elmar Jaeckel, Co-Leader Liver Transplant program MHH, Group Leader "Immune tolerance" in the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School.